Suppr超能文献

益生菌

Probiotics.

作者信息

Gupta V, Garg R

机构信息

Department of Microbiology, GMCH, Chandigarh, India.

出版信息

Indian J Med Microbiol. 2009 Jul-Sep;27(3):202-9. doi: 10.4103/0255-0857.53201.

Abstract

The term "probiotic" was first used in 1965, by Lilly and Stillwell, to describe substances secreted by one organism which stimulate the growth of another. The use of antibiotics, immunosuppressive therapy and irradiation, amongst other means of treatment, may cause alterations in the composition and have an effect on the GIT flora. Therefore, the introduction of beneficial bacterial species to GI tract may be a very attractive option to re-establish the microbial equilibrium and prevent disease. Prebiotic is a non-digestible food ingredient that confers benefits on the host by selectively stimulating one bacterium or a group of bacteria in the colon with probiotic properties. Both probiotics and prebiotics are together called as Synbiotics. Various bacterial genera most commonly used in probiotic preparations are Lactobacillus, Bifidobacterium, Escherichia, Enterococcus, Bacillus and Streptococcus . Some fungal strains belonging to Saccharomyces have also been used. Probiotics have been shown to be effective in varied clinical conditions- ranging from infantile diarrhoea, necrotizing enterocolitis, antibiotic-associated diarrhoea, relapsing Clostridium difficle colitis, Helicobacter pylori infections, inflammatory bowel disease to cancer, female uro-genital infection and surgical infections. Lactobacillus rhamnosus strain GG has proven beneficial affects on intestinal immunity. It increases the number of IgA and other immunoglobulins secreting cells in the intestinal mucosa. It also stimulates local release of interferons. It facilitates antigen transport to underlying lymphoid cells, which serves to increase antigen uptake in Peyer's patches. Probiotics are live microorganisms, so it is possible that they may result in infection in the host. The risk and morbidity of sepsis due to probiotic bacteria should be weighed against the potential for sepsis due to more pathological bacteria and the morbidity of diseases for which probiotic bacteria are being used as therapeutic agents. Also, future, well-designed placebo controlled studies with validated results are required for ascertaining the true health benefits of probiotics The important point in this regard is careful selection of the probiotic agent, its dose standardization and a thorough knowledge of its beneficial effects.

摘要

“益生菌”一词于1965年由 Lilly 和 Stillwell 首次使用,用于描述一种生物体分泌的刺激另一种生物体生长的物质。抗生素的使用、免疫抑制疗法和辐射以及其他治疗手段,可能会导致肠道菌群组成的改变并对其产生影响。因此,将有益细菌引入胃肠道可能是重建微生物平衡和预防疾病的极具吸引力的选择。益生元是一种不可消化的食物成分,通过选择性地刺激结肠中具有益生菌特性的一种细菌或一组细菌,从而为宿主带来益处。益生菌与益生元一起被称为合生元。益生菌制剂中最常用的各种细菌属包括乳酸杆菌属、双歧杆菌属、大肠杆菌属、肠球菌属、芽孢杆菌属和链球菌属。一些属于酿酒酵母属的真菌菌株也已被使用。益生菌已被证明在多种临床病症中有效,从婴儿腹泻、坏死性小肠结肠炎、抗生素相关性腹泻、复发性艰难梭菌结肠炎、幽门螺杆菌感染、炎症性肠病到癌症、女性泌尿生殖系统感染和手术感染。鼠李糖乳杆菌 GG 菌株已被证明对肠道免疫有益。它会增加肠道黏膜中分泌 IgA 和其他免疫球蛋白的细胞数量。它还会刺激干扰素的局部释放。它有助于将抗原转运到下层淋巴细胞,这有助于增加派尔集合淋巴结中的抗原摄取。益生菌是活的微生物,因此它们有可能在宿主体内引发感染。应权衡益生菌导致败血症的风险和发病率与更多致病细菌导致败血症的可能性以及使用益生菌作为治疗剂的疾病的发病率。此外,未来需要精心设计且结果经过验证的安慰剂对照研究,以确定益生菌真正的健康益处。在这方面的重点是谨慎选择益生菌制剂、其剂量标准化以及对其有益效果的全面了解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验